Van Hulzen Asset Management, LLC Haemonetics Corp Transaction History
Van Hulzen Asset Management, LLC
- $1.38 Billion
- Q3 2024
A detailed history of Van Hulzen Asset Management, LLC transactions in Haemonetics Corp stock. As of the latest transaction made, Van Hulzen Asset Management, LLC holds 13,890 shares of HAE stock, worth $989,523. This represents 0.08% of its overall portfolio holdings.
Number of Shares
13,890Holding current value
$989,523% of portfolio
0.08%Shares
1 transactions
Others Institutions Holding HAE
# of Institutions
332Shares Held
54MCall Options Held
689KPut Options Held
345K-
Black Rock Inc. New York, NY5.96MShares$425 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.17MShares$368 Million0.01% of portfolio
-
Capital Research Global Investors Los Angeles, CA4.44MShares$316 Million0.08% of portfolio
-
Wellington Management Group LLP Boston, MA4.2MShares$299 Million0.06% of portfolio
-
Neuberger Berman Group LLC New York, NY4.03MShares$287 Million0.26% of portfolio
About HAEMONETICS CORP
- Ticker HAE
- Exchange NYSE
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 51,316,500
- Market Cap $3.66B
- Description
- Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...